Fennec Pharmaceuticals Inc FENC

NAS: FENC | ISIN: CA31447P1009   4/06/2025
7,675 USD (-2,54%)
(-2,54%)   4/06/2025

29 juni 2023 · Far Eastern New Century staat wereldwijd op de eerste plaats met zijn prestaties op vlak van circulariteit · Persbericht

7 april 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

24 maart 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

17 maart 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

14 maart 2022 · FENC Investors Have Opportunity to Lead Fennec Pharmaceuticals Inc. Securities Fraud Lawsuit · Persbericht

10 maart 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

3 maart 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

24 februari 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

17 februari 2022 · FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

11 februari 2022 · FENC Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm · Persbericht

Mijn selecties